Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CYTK compared with DNLI: revenue, margins and what each company keeps, and the suppliers and customers both name
CYTK
Cytokinetics Inc
Change
Mkt cap
Revenue
Revenue
DNLI
Denali Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CYTK
Cytokinetics Inc
vs
DNLI
Denali Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CYTK, solid
DNLI, dashed
CYTK
Cytokinetics Inc
Change
62.31
▲
+0.45%
· post 62.59
Mkt cap
$8.7B
Revenue
$29M
Q2 FY26
Revenue
$88M
FY25
DNLI
Denali Therapeutics Inc.
Change
19.46
▲
+3.19%
· post 20.48
Closed
Nov 3 '26
Mkt cap
$3.1B
Revenue
$18M
Q3 FY26
Revenue
—
vs
Compare
Closed
Nov 3 '26
CYTK
Cytokinetics Inc
vs
DNLI
Denali Therapeutics Inc.
62.31
▲
+0.45%
post 62.59
Price
19.46
▲
+3.19%
post 20.48
$8.7B
Mkt cap
$3.1B
Q2 FY26
$29M
Revenue
$18M
Q3 FY26
FY25
$88M
Revenue
—
Change
Change
CYTK
62.31
▲
+0.45%
vs
DNLI
19.46
▲
+3.19%
Closed
Nov 3 '26